Clario announces investment in new translation service technology to reduce eCOA study start-up times and increase global patient access to clinical trials
- Friday, August 12, 2022, 7:04
- Finance
- Add a comment
Leading clinical trial endpoint technology provider sets ambitious targets to reduce translation timelines by 20-30% with investment in new technology and processes PHILADELPHIA, Aug. 12, 2022 /PRNewswire/ — Clario, a technology company that delivers the leading endpoint technology…
About the Author
adminasapcorp has written 41821 stories on this site.